论文部分内容阅读
一、国内原药及中间体市场行情监测本月随着上海ACE和“十九大”会议的结束,各工厂陆续恢复生产,但上游原材料及中间体供应依旧紧张,原药厂家交单压力巨大,库存低位,供应局势十分紧张,调价毁单现象频出,各原药品种的市场报价不断上涨。另一方面,由于高位的原药成本未能顺利地传导到终端,制剂工厂对高价位品种持谨慎态度,实际交投较少,对下游的冬储款大多采取定量不定价的策略。临近供暖期,市场对“2+26”城市错峰生产的关
I. Market Surveillance of Domestic Raw Materials and Intermediates This month, with the conclusion of the Shanghai ACE and the “19th National Congress”, the factories resumed production one after another, but the supply of raw materials and intermediates in the upstream remained tight. The original drug manufacturers submitted a single The pressure is huge, stocks low, the supply situation is very tight, frequent price adjustment destroyed the single, the market price of the original drug varieties rising. On the other hand, due to the high cost of the original drug failed to be successfully transmitted to the terminal, the preparation plant cautious for the high price varieties, the actual transaction less, most of the downstream winter savings to take a quantitative pricing strategy. Adjacent to the heating period, the market on the “2 +26 ” off peak city production off